Azathioprine for glucocorticoid resistant noninfectious uveitis.

Abstract

AZA is safe and effective in corticosteroid-sparing and controlling inflammation in CRNIU. Its low cost and availability allow proposing it as a first-line option, especially when new biological treatments are difficult to obtain.